Mark Nance
Algemeen Adviseur bij ENVISTA HOLDINGS CORPORATION
Vermogen: 596 196 $ op 30-04-2024
Actieve functies van Mark Nance
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ENVISTA HOLDINGS CORPORATION | Algemeen Adviseur | 01-09-2019 | - |
Bedrijfssecretaris | 01-09-2019 | - |
Loopbaan van Mark Nance
Eerdere bekende functies van Mark Nance
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INSYS THERAPEUTICS, INC. | Algemeen Adviseur | 10-10-2018 | 31-07-2019 |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Algemeen Adviseur | 01-04-2012 | 01-05-2017 |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Algemeen Adviseur | - | - |
GE Healthcare Medical Diagnostics | Algemeen Adviseur | - | - |
Integrated Nano-Technologies LLC | Corporate Officer/Principal | - | - |
GE AEROSPACE | Algemeen Adviseur | - | - |
Opleiding van Mark Nance
University of Missouri | Undergraduate Degree |
Cornell Law School | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Verenigd Koninkrijk | 4 |
Operationeel
General Counsel | 6 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Producer Manufacturing | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GE AEROSPACE | Producer Manufacturing |
ENVISTA HOLDINGS CORPORATION | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Integrated Nano-Technologies LLC | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
GE Healthcare Medical Diagnostics | |
INSYS Therapeutics, Inc.
INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
- Beurs
- Insiders
- Mark Nance
- Ervaring